cme
Current Pacemaker and Defibrillator Therapy
Dtsch Arztebl Int 2011; 108(21): 372-80. DOI: 10.3238/arztebl.2011.0372
;
| 1. | Bayes de Luna A: Sudden death in ischemic heart disease. Rev Port Cardiol 1990; 9: 473–9. MEDLINE |
| 2. | Ellenbogen KA, Wilkoff BL, Lau CP (eds.): Clinical cardiac pacing, defibrillation and resynchronization therapy. 3rd edition. Philadelphia: Saunders Elsevier 2006, 1–1280. |
| 3. | Lemke B, Nowak B, Pfeiffer D: Leitlinien zur Herzschrittmachertherapie. Z Kardiol 2005; 94: 704–20. MEDLINE |
| 4. | Rybak K, Nowak B, Pfeiffer D, Fröhlich G, Lemke B: Kommentar zu den ESC-Leitlinien „Guidelines for cardiac pacing and cardiac resynchronization therapy“. Kardiologe 2008; 2: 463–78. |
| 5. | Wellens HJJ, Conover B: The ECG in acute ST-segment elevation MI. In: Wellens HJJ, Conover B (eds.): The ECG in emergency decision making. 2nd edition. WB Saunders Company, St. Louis, 2006; 1–53. |
| 6. | Markewitz A: Jahresbericht 2008 des Deutschen Herzschrittmacher-Registers. |
| 7. | Carlson MD, Ip J, Messenger F, for the ADOPT investigators: A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003; 42: 627–33. MEDLINE |
| 8. | Jung W, Andresesen D, Block M, et al.: Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 2006; 95: 696–708. MEDLINE |
| 9. | Conolly SJ, Gent M, Roberts S, et al.: Canadian implantable defibrillator study (CIDS): A randomised trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297–302. MEDLINE |
| 10. | Kuck KH, Cappato R, Siebels J, et al.: Randomised comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748–54. MEDLINE |
| 11. | The Antiarrhythmics versus Implantable defibrillators (AVID) investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from nearfatal ventricular arrhythmia. N Engl J Med 1997; 337: 1576–83. MEDLINE |
| 12. | Moss AJ, Hall WJ, Cannom DS, et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933–40. MEDLINE |
| 13. | Moss AJ, Zareba W, Hall WJ, et al.: The Multicenter Automatic Defibrillator Implantation Trial II Investigators: prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877–83. MEDLINE |
| 14. | Bardy GH, Lee KL, Mark DB: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225–37. MEDLINE |
| 15. | Hohnloser SH, Kuck KH, Dorian P, et al. on behalf of the DINAMIT investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481–8. MEDLINE |
| 16. | Bänsch D, Antz M, Boczor S: Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002; 105: 1453–8. MEDLINE |
| 17. | Kadish A, Dyer A, Daubert JP, et al.: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 351: 2151–8. MEDLINE |
| 18. | Strickberger SA, Hummel JD, Bartlett TG: Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia – AMIOVIRT. J Am Coll Cardiol 2003; 41: 1707–12. MEDLINE |
| 19. | Abraham WT, Fisher WG, Smith AL, et al., for the MIRACLE study group: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845–53. MEDLINE |
| 20. | Cazeau S, Leclerq C, Lavergne T, et al.: Multisite stimulation in cardiomyopathies (MUSTIC) study investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873–80. MEDLINE |
| 21. | Bristow M, Saxon L, Boehmer J, et al.: Cardiac resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140–50. MEDLINE |
| 22. | Cleland JG, Daubert JC, Erdmann E, et al.: The effect of resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539–49. MEDLINE |
| 23. | Saxon LA, Hayes DL, Day J, et al.: Survival after ICD and CRT-D implant in a large cohort of heart failure patients treated with contemporary drug and device therapies—results of the ALTITUDE study. J Heart Rhythm 2009; 29: 301 (Abstract). |
| 24. | Moss AJ, Hall WJ, Cannom DS: Cardiac resynchronization therapy for the prevention of heart failure events. N Engl J Med 2009; 361: 1329–38. MEDLINE |
| 25. | Klein H, Krämer A, Pieske BM, Trappe HJ, De Vries H: Fahreignung bei kardiovaskulären Erkrankungen. Kardiologe 2010; 4: 441–73. |
